Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 753.15 K1.23 M2.02 M899.88 K 4.91 M Research & development 95.16 K141.08 K93.11 K61.95 K 391.3 K Operating income -848.31 K-1.38 M-2.12 M-2.51 M -6.85 M Non-Operating Income, Total -7.51 M-6.04 M2.86 M-1.88 M -12.57 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses -7.51 M-6.04 M2.87 M-1.88 M -12.57 M Unusual income/expense -121-95-632-132 -980 Pretax income -8.36 M-7.42 M746.86 K-19.42 M -34.46 M Equity in earnings ———— — Taxes ———-1.08 M — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -8.36 M-7.42 M746.86 K-4.39 M -19.42 M Discontinued operations ———— — Net income -8.36 M-7.42 M746.86 K-4.39 M -19.42 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -8.36 M-8.42 M-1.56 M-4.87 M -23.21 M Basic earnings per share (Basic EPS) -1.23-1.24-0.17-0.13 -2.77 Diluted earnings per share (Diluted EPS) -1.23-1.24-0.17-0.13 -2.77 Average basic shares outstanding 6.8 M6.8 M9.26 M8.38 M — Diluted shares outstanding 6.8 M6.8 M9.26 M8.38 M — EBITDA ———— — EBIT -848.31 K-1.38 M-2.12 M-2.51 M -6.85 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —